Drug Trial Radar · NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Last checked: Nov 19, 2026Latest source record: Mar 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Jun 26, 2025
Primary completion
Apr 30, 2027
Study completion Feb 4, 2028
Sponsor
- Lead sponsor
- Mirador Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
Conditions
- Inflammatory Bowel Disease (IBD)
- Ulcerative Colitis (UC)
- Crohn's Disease
Interventions
MT-501Drug
MT-501
MT-201Drug
MT-201
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess the proportion of participants reporting treatment emergent adverse events (TEAEs), serious adverse events (SAEs), adverse events (AEs) leading to discontinuation, and markedly abnormal laboratory valuesTime frame: Up to 13 weeks
- Assess the Proportion of Participants with Endoscopic Response (CD)Time frame: 13 weeks
- Assess the Proportion of Participants Endoscopic Improvement (UC)Time frame: 12 weeks
- Assess the Proportion of Participants with Clinical Remission (CD)Time frame: 13 weeks
- Assess the Proportion of Participants with Clinical Remission (UC)Time frame: 12 weeks
Locations
66 sites in 5 countries. Site status is shown where the registry gives one.
Mirador Therapeutics Selected Site
Birmingham, Alabama · Recruiting
Mirador Therapeutics Selected Site
Scottsdale, Arizona · Recruiting
Mirador Therapeutics Selected Site
Sun City, Arizona · Recruiting
Mirador Therapeutics Selected Site
Little Rock, Arkansas · Recruiting
Mirador Therapeutics Selected Site
Little Rock, Arkansas · Recruiting
Mirador Therapeutics Selected Site
Colorado Springs, Colorado · Recruiting
Mirador Therapeutics Selected Site
Littleton, Colorado · Recruiting
Mirador Therapeutics Selected Site
Miami, Florida · Recruiting
Mirador Therapeutics Selected Site
Miami, Florida · Recruiting
Mirador Therapeutics Selected Site
Miami, Florida · Recruiting
Mirador Therapeutics Selected Site
Orlando, Florida · Recruiting
Mirador Therapeutics Selected Site
Palmetto Bay, Florida · Recruiting
Mirador Therapeutics Selected Site
Pensacola, Florida · Recruiting
Mirador Therapeutics Selected Site
Atlanta, Georgia · Recruiting
Mirador Therapeutics Selected Site
Snellville, Georgia · Recruiting
Mirador Therapeutics Selected Site
Glenview, Illinois · Recruiting
Mirador Therapeutics Selected Site
Gurnee, Illinois · Recruiting
Mirador Therapeutics Selected Site
Lafayette, Louisiana · Recruiting
Mirador Therapeutics Selected Site
Marrero, Louisiana · Recruiting
Mirador Therapeutics Selected Site
Shreveport, Louisiana · Recruiting
Mirador Therapeutics Selected Site
Ypsilanti, Michigan · Recruiting
Mirador Therapeutics Selected Site
Bridgeton, Missouri · Recruiting
Mirador Therapeutics Selected Site
Kansas City, Missouri · Recruiting
Mirador Therapeutics Selected Site
Liberty, Missouri · Recruiting
Mirador Therapeutics Selected Site
Las Vegas, Nevada · Recruiting
Mirador Therapeutics Selected Site
New York, New York · Recruiting
Mirador Therapeutics Selected Site
Rochester, New York · Recruiting
Mirador Therapeutics Selected Site
High Point, North Carolina · Recruiting
Mirador Therapeutics Selected Site
Raleigh, North Carolina · Recruiting
Mirador Therapeutics Selected Site
Cincinnati, Ohio · Recruiting
Mirador Therapeutics Selected Site
Liberty Township, Ohio · Recruiting
Mirador Therapeutics Selected Site
Providence, Rhode Island · Recruiting
Mirador Therapeutics Selected Site
Greenville, South Carolina · Recruiting
Mirador Therapeutics Selected Site
Cordova, Tennessee · Recruiting
Mirador Therapeutics Selected Site
Dallas, Texas · Recruiting
Mirador Therapeutics Selected Site
Garland, Texas · Recruiting
Mirador Therapeutics Selected Site
Georgetown, Texas · Recruiting
Mirador Therapeutics Selected Site
Houston, Texas · Recruiting
Mirador Therapeutics Selected Site
Lubbock, Texas · Recruiting
Mirador Therapeutics Selected Site
Southlake, Texas · Recruiting
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.